coumadin
Study compares dabigatran to warfarin in treating blood clots
- Fri, 06/08/2012 - 12:31pm
A study headed by Boehringer Ingelheim, the maker of Pradaxa, suggests a fixed dose of dabigatran therapy twice daily
A study headed by Boehringer Ingelheim, the maker of Pradaxa, suggests a fixed dose of dabigatran therapy twice daily
From side effects to recalls to pending lawsuits, Consumer Drug Report keeps you up to date with the latest information on pharmaceutical safety.
To submit questions or story ideas, please post on our Consumer Drug Report Facebook page,
tweet at us @ConsumerDrugRep, or
email us at news@consumer-drug-report.com.
Brought to you by Spangenberg Shibley & Liber, LLP © 2012